Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies

Bleeding events in patients with leukemia or malignant tumors can seriously complicate diagnostic interventions or therapeutic procedures, and may increase cancer-associated morbidity and mortality. Bleeding signs due to thrombocytopenia are frequent, especially in patients with malignant